SCHEMBL5160533

SCHEMBL5160533

COc1ccc(Cl)cc1-c1c(CCCO)c(=O)[nH]c2c(C(F)(F)F)cccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 4/20 0.61
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
CAPN1 P07384 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
GAA P10253 2/20 0.36
PGR P06401 3/20 0.36
NR3C1 P04150 2/20 0.35
NR3C2 P08235 2/20 0.35
AR P10275 1/20 0.35
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 4/20 0.35
HPGD P15428 3/20 0.35
POLB P06746 2/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5163422 0.94 CYP2C9 (0.68) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5162844 0.92 CYP2C9 (0.58) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5159329 0.87 CYP2C9 (0.58) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL7485354 0.84 CYP2C9 (0.48) CYP2C9CAPN1SMN1; SMN2GAAPGR
SCHEMBL5157420 0.84 CYP2C9 (0.49) CYP2C9CAPN1SMN1; SMN2PGRNR3C1
SCHEMBL5159376 0.81 CYP2C9 (0.89) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5157842 0.81 CYP2C9 (0.47) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5161821 0.81 CYP2C9 (0.66) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5159666 0.80 CYP2C9 (0.46) CYP2C9CAPN1SMN1; SMN2GAAPGR
SCHEMBL5161358 0.80 CYP2C9 (0.46) CYP2C9CAPN1SMN1; SMN2GAAPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1133474-B1 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS BRISTOL MYERS SQUIBB CO (US) 2007-02-21 EP claimed